Talk:Lemborexant
Add topic| This is the talk page for discussing improvements to the Lemborexant article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lemborexant.
|
Wiki Education Foundation-supported course assignment
[edit]
This article was the subject of a Wiki Education Foundation-supported course assignment, between 1 September 2021 and 6 December 2021. Further details are available on the course page. Student editor(s): Tardigrade3.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 00:02, 18 January 2022 (UTC)
Structure
[edit]The 2-D structure is wrong, it is a dimethyl pyrimidine, not a trim ethyl pyrimidine. The INN Drug list has the correct structure, and the IUPAC name is correct. I'll fix it, if I can get a few minutes today. -217.111.185.11
Significance of faster receptor dissociation
[edit]The article says "lemborexant dissociates from the orexin receptors more rapidly than does suvorexant". The reference talks about a dissociation in just 11 minutes. I'm not sure how relevant this is.. and this may be a bit misleading when comparing the possibility of next day effects to other products. The concentration in the blood seems to be what matters! With such a high half life, I would expect that to build up (please correct me if I'm missing something). Danski14(talk) 15:51, 3 August 2023 (UTC)